LENSAR, Inc. (LNSR) Misses Q1 EPS by 23c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/4/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update
May 5, 2021 7:00 AM EDTFirst Quarter 2021 Procedure Volumes Increase 21.1% over First Quarter 2020
Cash and Cash Equivalents of $35.9 Million as of March 31, 2021
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the first quarter ended March 31, 2021 and provided an update on key strategic and operational initiatives.
2021 is off to an encouraging start as we have continued to... More
